Kazuhiko Ochiai

11PUBLICATIONS
11CO-AUTHORS
Fish physiology and geneticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 24, 2026
Oxidative Stress-Mediated Mitochondrial Dysfunction Drives Genistein-Induced Apoptosis in TM4 Sertoli and ELT3 Leiomyoma Cells.

|Jun 26, 2026
Molecular Characterization of Hotspot Mutations in HER2, BRAF, KRAS, and PIK3CA in Canine Pulmonary Adenocarcinoma from Japan.

|Jun 26, 2025
Antitumor Effect of mTOR1/2 Dual Inhibitor AZD8055 in Canine Pulmonary Carcinoma.

Tomokazu Nagashima, Kazuhiko Ochiai, Yuka Takizawa

|Apr 13, 2025
Knockdown of Methylenetetrahydrofolate Dehydrogenase/Cyclohydrolase 2 Promotes an Epithelial-Like Phenotype in Canine Mammary Carcinoma Cells.

Yukino Machida, Remika Onagi, Kazuhiko Ochiai

|Feb 28, 2023
A Highly Conserved Region in BRCA2 Suppresses the RAD51-Interaction Activity of BRC Repeats.

Zida Zhu, Taisuke Kitano, Masami Morimatsu

|Feb 06, 2023
Establishment of a BRAF V595E-mutant canine prostate cancer cell line and the antitumor effects of MEK inhibitors against canine prostate cancer.

Masanori Kobayashi, Moe Onozawa, Shiho Watanabe

Pageof 2

Frequent Collaborators

3 joint publications

Masaki Michishita

2 joint publications

Makoto Bonkobara

2 joint publications

Yasunaga Yoshikawa

2 joint publications

Masami Morimatsu